A California biotech company that had expressed frustration over Wisconsin’s stem-cell patents has signed a licensing agreement for stem-cell technologies with the Wisconsin Alumni Research Foundation.
“We were able to work out our differences,” said Joydeep Goswami, vice president for stem cells and regenerative medicine at Invitrogen Corp. of Carlsbad, Calif.
Invitrogen, which announced the agreement Thursday, is one of the largest of 25 companies that have signed 30 licensing agreements for stem cells with WARF, said licensing manager Andy DeTienne.